PRESTIGE CONSUMER HEALTHCARE INC. Total Liabilities
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Total Liabilities of $2.65 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-06
- 2026-06-30: Liabilities $2.65B.
- 2026-03-31: Liabilities $1.61B.
- 2025-12-31: Liabilities $1.67B.
- 2025-09-30: Liabilities $1.62B.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $2.65B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.61B 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $1.67B 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $1.62B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.58B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.57B 10-K · filed 2026-05-14 | |
| 2024-12-31 | $1.54B 10-Q · filed 2025-02-06 | |
| 2024-09-30 | $1.59B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.63B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.66B 10-K · filed 2025-05-09 | |
| 2023-12-31 | $1.74B 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $1.80B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.87B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.91B 10-K · filed 2024-05-15 | |
| 2022-12-31 | $2.06B 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $2.06B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $2.10B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $2.09B 10-K · filed 2023-05-05 | |
| 2021-12-31 | $2.14B 10-Q · filed 2022-02-03 | |
| 2021-09-30 | $2.21B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.14B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.07B 10-K · filed 2022-05-06 | |
| 2020-12-31 | $2.15B 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $2.16B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.22B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.34B 10-K · filed 2021-05-07 | |
| 2019-12-31 | $2.31B 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $2.35B 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $2.36B 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $2.35B 10-K · filed 2020-05-08 | |
| 2018-12-31 | $2.43B 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $2.50B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $2.61B 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $2.58B 10-K · filed 2019-05-13 | |
| 2017-12-31 | $2.68B 10-Q · filed 2018-02-01 | |
| 2017-09-30 | $3.01B 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $3.04B 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $3.09B 10-K · filed 2018-05-10 | |
| 2016-12-31 | $2.01B 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $2.06B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $2.14B 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $2.20B 10-K · filed 2017-05-17 | |
| 2015-12-31 | $1.92B 10-Q · filed 2016-02-04 | |
| 2015-09-30 | $1.94B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.97B 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $2.01B 10-K · filed 2016-05-17 | $2.04B 10-K · filed 2015-05-14 |
| 2014-12-31 | $2.07B 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $2.13B 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.27B 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.23B 10-K · filed 2015-05-14 | |
| 2013-12-31 | $1.32B 10-Q · filed 2014-02-07 | |
| 2013-09-30 | $1.27B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $1.24B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $1.26B 10-K · filed 2014-05-19 | |
| 2012-12-31 | $1.27B 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $1.35B 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $1.33B 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $1.36B 10-K · filed 2013-05-17 | |
| 2011-12-31 | $644.20M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $663.69M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $670.87M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $695.09M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |